Skip to main content

Leukemia, lymphoma, and myeloma.

265 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Leukemia, lymphoma, and myeloma265 studies

AML or MDS Undergoing Reduced-Intensity TransplantPhase 1NCT06996119

Emapalumab for GVHD Prevention After Transplant

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

City of Hope Medical CenterOpen the brief

Acute Myeloid Leukemia, Relapsed, AdultФаза 2NCT06802315

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Intensity modulated total marrow irradiation, Cyclophosphamide (CTX), Fludarabine (Fludara), Busulfan (conditioning for ALLO Transplant)

University of Illinois ChicagoOpen the brief

Acute Lymphoblastic LeukemiaPhase 1/2NCT03128034Papers

Cyclosporine

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Fred Hutchinson Cancer CenterOpen the brief

Acute Myeloid LeukemiaPhase 1NCT04024761Papers

CIML NK

CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

Dana-Farber Cancer InstituteOpen the brief

Acute Myeloid LeukemiaPhase 1NCT03113643Papers

SL-401

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Dana-Farber Cancer InstituteOpen the brief

Untreated Nodal T Follicular Helper Cell LymphomaPhase 1NCT07278856

Ruxolitinib + CHOP

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical CenterOpen the brief

Multiple MyelomaPhase 1NCT07581704

Sirolimus

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

Christopher StrouseOpen the brief

Recurrent Acute Lymphoblastic LeukemiaPhase 1NCT05418088

Anti-CD19/CD20/CD22 CAR T-Cells

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Sumithira VasuOpen the brief

AML/MDSPhase 1NCT04318678Papers

CD123-CAR T

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

St. Jude Children's Research HospitalOpen the brief

Acute Myeloid Leukemia and Other Myeloid MalignanciesPhase 1/2NCT06928662

Decitabine + FLAG-Ida and Total-Body Irradiation

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer CenterOpen the brief

Clinical trials: Phase 1 and Phase 2, explained